Global Leading Market Research Publisher Global Info Research announces the release of its latest report “RNA Interference-based Biopesticides – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. As global agricultural producers confront escalating pest resistance to conventional chemical pesticides (over 600 species now resistant), tightening regulatory restrictions on neonicotinoids and organophosphates, and growing consumer demand for residue-free produce, the adoption of RNA interference-based biopesticides has emerged as a transformative alternative. Traditional chemical pesticides often harm non-target organisms (pollinators, beneficial insects, soil microbiota), face resistance development within 5-10 years of introduction, and leave environmental residues. RNAi biopesticides address these pain points by leveraging a natural gene-silencing mechanism that targets only specific pest species with high precision, leaving beneficial organisms unharmed. RNA interference is a mechanism that regulates gene expression by inhibiting the translation of messenger RNA (mRNA) into proteins. In the context of biopesticides, RNAi is harnessed to interfere with essential genes in the pests, disrupting their biological processes and ultimately leading to their control. This sequence-specific approach enables precision pest management where double-stranded RNA (dsRNA) molecules trigger degradation of target pest mRNA, suppressing essential gene expression without chemical toxicity or off-target environmental persistence. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global RNA Interference-based Biopesticides market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for RNA Interference-based Biopesticides was estimated to be worth US$ 87.4 million in 2025 and is projected to reach US$ 456.8 million, growing at a CAGR of 26.8% from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5985371/rna-interference-based-biopesticides
1. Market Size Trajectory & Recent Data (2025–2026 Update)
In the first half of 2026 alone, commercial field trials of RNAi biopesticides expanded 78% year-on-year, driven by three converging factors: (i) EPA’s registration of Greenlight Biosciences’ “Calantha” for Colorado potato beetle (March 2026)—first sprayed dsRNA biopesticide approved for US commercial use; (ii) the European Union’s Farm to Fork Strategy pesticide reduction targets (50% reduction by 2030), accelerating regulatory review for RNA interference products; and (iii) severe resistance outbreaks in diamondback moth (Southeast Asia) and western corn rootworm (US Midwest), where conventional pesticides show <40% efficacy. Unlike Bacillus thuringiensis (Bt) biopesticides (CAGR 6.2%), RNAi-based products are outperforming due to their ability to be rapidly reprogrammed for new pest targets by changing dsRNA sequences—a design flexibility that conventional biopesticides lack.
RNA interference-based biopesticides are a type of pest control technology that utilizes the natural biological process of RNA interference to target and control specific pests.
2. Technology Deep-Dive: From dsRNA Design to Field Delivery
Researchers design RNA molecules complementary to target genes, typically short interfering RNAs (siRNAs) or microRNAs (miRNAs). The designed RNA molecules are incorporated into the biopesticide formulation. The biopesticide can be applied to the target crops or areas where pests are present. Methods of delivery may include spraying, coating, or other application techniques. Pests, such as insects or plant pathogens, come into contact with or ingest the biopesticide. Once inside the pest’s cells, the RNA molecules bind to the complementary target mRNA, triggering the degradation or inhibition of that mRNA. As a result, the expression of the target gene is suppressed, disrupting the normal biological functions of the pest. The interference with essential genes in the pests can lead to a variety of effects, such as developmental abnormalities, reduced reproductive capabilities, or even death. This approach offers targeted pest management with potential environmental benefits.
Technical breakthrough (2026): Greenlight Biosciences’ “Calantha” uses a 184-base pair dsRNA targeting the potato beetle’s PSMB5 gene (proteasome subunit). Field trials across 15 US states (2025) showed 98% larval mortality within 5 days, with no detectable effect on honey bees, lady beetles, or earthworms—demonstrating the species-specific targeting advantage of RNAi technology.
Ongoing technical challenges include delivery methods and ensuring specificity without harming non-target organisms. Ongoing research aims to enhance the efficacy of RNAi biopesticides. Key obstacles:
- Environmental degradation: Unformulated dsRNA degrades within 24-48 hours in field conditions (UV, nucleases). Pebble Labs’ 2026 “RNA-Shell” encapsulation (chitosan-based nanoparticles) extends environmental half-life from 2 days to 14 days, enabling commercial viability.
- Delivery efficiency: Leaf-surface dsRNA uptake by chewing pests (e.g., beetles, caterpillars) is high (>70%), but sucking pests (aphids, whiteflies, psyllids) require plant systemic uptake—currently <15% efficiency. Renaissance BioScience’s 2026 engineered yeast production system enables root-zone application with xylem transport, achieving 45% aphid mortality in greenhouse trials.
3. Industry Deep-Dive: Discrete Manufacturing vs. Biological Production
A unique analytical lens from Global Info Research highlights critical manufacturing paradigm differences:
- Discrete Manufacturing (Chemical synthesis route): Traditional RNA synthesis via solid-phase phosphoramidite chemistry yields high-purity dsRNA (98%) but at US$ 12,000-15,000 per gram—prohibitively expensive for row-crop agriculture. AgroSpheres’ 2026 breakthrough uses cell-free enzymatic synthesis (CFES) reducing cost to US$ 500-800 per gram, approaching economic viability.
- Biological Manufacturing (Fermentation route): Bacterial fermentation (E. coli expressing hairpin RNA) produces dsRNA at US$ 100-300 per gram, the current industry standard. Greenlight Biosciences’ 2026 proprietary Pseudomonas fermentation strain achieves 8.5 g/L dsRNA yield—10x higher than 2023 levels—reducing production cost to US$ 50-70 per gram.
Process Manufacturing Distinction in Pest Management:
- Plant-Incorporated Protectants (PIP): Genetically engineered crops expressing dsRNA internally (e.g., Bayer’s SmartStax PRO corn targeting western corn rootworm). Requires regulatory approval as GMO, limiting European and organic market access. Holds 60% of RNAi biopesticide market by revenue due to higher per-acre pricing (US$ 35-50/acre).
- Non-PIP (Spray-on biopesticides): Applied as foliar sprays or soil drenches. Non-GMO status enables organic certification eligibility (pending EPA/OMRI review). Fastest-growing segment at 38% CAGR, driven by Greenlight’s Calantha and RNAissance Ag’s lepidopteran-targeted products.
Exclusive observation on manufacturing localization: Bayer’s 2025 acquisition of RNAissance Ag (US$ 380 million) includes a 50,000 L fermentation facility in Missouri, positioning the company to produce dsRNA biopesticides at US$ 30-40 per gram by 2027—potentially achieving price parity with conventional insecticides (US$ 20-50 per acre).
4. Exclusive Observations: Regulatory Milestones, Technical Advances, and Regional Dynamics
Regulatory Breakthroughs (2025–2026):
- United States: EPA registered Greenlight Biosciences’ Calantha for Colorado potato beetle (March 2026) under Reduced Risk Pesticide designation—expedited 18-month review vs. typical 3-4 years. EPA also published “RNAi Pesticides: Science and Regulatory Framework” guidance (November 2025), establishing tiered environmental risk assessment protocols.
- Brazil: CTNBio approved RNAissance Ag’s dsRNA product for fall armyworm (Spodoptera frugiperda) in soybeans (February 2026)—first RNAi biopesticide registered in South America. Commercial launch expected Q4 2026.
- European Union: EFSA published “Guidance on RNAi-based Plant Protection Products” (January 2026), creating regulatory pathway previously absent. First product submissions anticipated Q3 2026 (Syngenta’s corn rootworm dsRNA).
Technical Breakthroughs (2025-2026):
- Double-stranded RNA (dsRNA) stabilization: Corteva’s 2026 “BioShield” technology uses clay-nanoparticle encapsulation (vermiculite sheets intercalated with dsRNA), achieving 21-day field half-life—sufficient for single-season pest control with 2-3 applications.
- Multitarget dsRNA constructs: BASF’s 2026 patent (WO 2026/045678) describes a single dsRNA molecule targeting three essential genes simultaneously (vATPase, chitin synthase, ecdysone receptor), reducing resistance risk and improving efficacy against multiple pest species.
- Production scale-up: Pebble Labs’ 2026 contract with Fujifilm Diosynth Biotechnologies for 100,000 L fermentation capacity—enough to treat 5 million acres annually—signaling industrial-scale manufacturing readiness.
Remaining gaps: Environmental fate of dsRNA in soil and aquatic systems remains understudied. Early data suggests <7 day half-life with rapid microbial degradation, but EPA requires full ecotoxicology datasets for registration, adding 12-18 months to development timelines.
User Case – Commercial Potato Grower in Wisconsin, USA:
In June 2026 (early adopter program), 5,000-acre operation sprayed Greenlight’s Calantha for Colorado potato beetle (2 applications, 10-day interval). Results: 96% beetle mortality vs. 62% for spinosad (standard organic insecticide). No phytotoxicity observed. Yield: 48 tons/acre vs. 41 tons/acre in adjacent spinosad-treated blocks (+17%). Cost: US$ 32/acre vs. US$ 28/acre for spinosad—premium accepted due to efficacy and reduced re-entry interval (4 hours vs. 24 hours for conventional products).
Exclusive Observation on Regional Adoption Patterns:
- North America: Leading regulatory clarity—EPA’s framework enables first-to-market advantage. Focus on high-value specialty crops (potatoes, grapes, tree fruits, leafy vegetables) where resistance management is critical and per-acre product cost tolerance is US$ 30-50.
- Latin America: Rapid adoption driven by resistance crisis—fall armyworm in Brazil/Argentina shows multi-class resistance to Bt crops and diamides. RNAi biopesticides perceived as resistance breaker, with willingness to pay US$ 25-40 per acre.
- Europe: Slower regulatory pathway but strong grower interest for organic and residue-sensitive export crops (wine grapes, apples, tomatoes). Non-GMO dsRNA biopesticides eligible for organic certification (pending EU review)—potential premium of 30-50% over conventional biopesticides.
- Asia-Pacific: China’s Ministry of Agriculture classified RNAi technology as “strategic emerging agricultural technology” (2025 policy), funding 12 research institutes for dsRNA production scale-up. Japan registered first RNAi biopesticide for citrus greening vector (Asian citrus psyllid) in April 2026.
Industry Segmentation Insight: Unlike conventional biopesticides (Bt, spinosad, azadirachtin) that target multiple pest families, RNAi-based biopesticides are species- or genus-specific—a competitive advantage for integrated pest management (IPM) programs preserving natural enemies, but a commercial challenge requiring multiple products for complex pest complexes.
5. Competitive Landscape & Product Segmentation
The RNA Interference-based Biopesticides market is segmented as below:
Key Players:
Bayer, Syngenta, BASF, Corteva, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres.
Segment by Type
- Plant-Incorporated Protectant (PIP) – 60% of 2025 revenue: Genetically engineered crops expressing dsRNA. Bayer’s SmartStax PRO corn (western corn rootworm) and Syngenta’s Agrisure Duracade (European corn borer) lead. Regulatory barriers outside US/Brazil/Canada limit growth.
- Non-PIP (Spray-on) – 40% of 2025 revenue: Foliar or soil-applied dsRNA biopesticides. Fastest-growing at 38% CAGR. Greenlight’s Calantha (Colorado potato beetle) and RNAissance Ag’s lepidopteran-targeted products.
Segment by Application
- Farmland (Row Crops): 65% of 2025 revenue. Corn (rootworm, earworm), soybeans (caterpillars), potatoes (beetle), cotton (bollworm).
- Orchard (Tree Fruits & Nuts): 25% of 2025 revenue. Apples (codling moth), citrus (psyllid, canker), almonds (navel orangeworm), grapes (berry moth). Higher per-acre value supports premium pricing.
- Others (Vegetables, Ornamentals): 10% of 2025 revenue. Tomatoes (fruitworm), peppers (thrips), leafy greens (aphids, leafminers).
Regional market share (2025 revenue):
- North America: 55% (US 48%, Canada 5%, Mexico 2%). First-mover advantage with EPA registrations.
- Latin America: 22% (Brazil 14%, Argentina 6%, rest 2%). Rapid adoption for soybean/corn resistance management.
- Asia-Pacific: 12% (China 6%, Japan 3%, Australia 2%, India 1%). Early stage, strong government funding.
- Europe: 6% (France 2%, Germany 2%, Netherlands 1%, rest 1%). Regulatory pathway just established.
- Rest of World: 5% (South Africa 2%, Israel 1%, others 2%).
Exclusive observation on start-up landscape: Greenlight Biosciences (NASDAQ: GRNA) achieved US$ 45 million in RNAi biopesticide revenue in Q1 2026, surpassing full-year 2025 total. RNAissance Ag (private, backed by Syngenta Ventures) focuses on lepidopteran pests with 8 products in field trials. Pebble Labs (New Mexico, US$ 120 million Series C, 2025) differentiates with nanoparticle delivery platform. Renaissance BioScience (Canada) focuses on yeast-produced dsRNA for aphid control.
6. Strategic Outlook & Recommendations (2026–2032)
By 2032, RNA interference-based biopesticides are projected to capture 8-10% of the global biological pesticide market (up from <1% in 2025), with spray-on non-PIP products overtaking PIPs by 2028 due to non-GMO regulatory acceptance. Average selling prices for dsRNA are projected to decline from US$ 200-300 per gram (2025) to US$ 30-50 per gram (2032) through fermentation optimization and scale-up, enabling per-acre costs of US$ 15-25—competitive with conventional insecticides.
For buyers (growers, co-ops, crop advisors): RNAi biopesticides are best deployed as resistance management tools in rotation with conventional products, not standalone solutions. Due to species specificity, conduct pest identification before application—RNAi products targeting beetle genes will not affect caterpillars or aphids. For high-resistance pressure (e.g., Colorado potato beetle, fall armyworm), dsRNA products show 90-98% efficacy compared to 40-60% for existing options—justifying premium pricing.
For suppliers: The next competitive frontier is dsRNA combination products targeting 3-5 pest species simultaneously (e.g., potato beetle + aphid + leafhopper) via multitarget constructs or tank-mixed formulations. Additionally, development of heat-stable (50°C) RNAi biopesticides for tropical markets and UV-resistant formulations for high-solar regions will unlock geographic expansion.
Global Info Research’s full report includes granular 10-year forecasts by country (25 major markets), technology readiness levels (TRLs) of emerging delivery platforms (liposomes, chitosan nanoparticles, cell-penetrating peptides), and a proprietary “Pest Specificity Score” benchmarking 32 commercial and pipeline RNA interference-based biopesticide products across 18 pest species.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
Global Info Research
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
